Reported studies have been revealed that SOD2 has been linked with the energy metabolism of colorectal cancer [50], oxidative stress in endocrine cancer [51], and stem cell reprogramming in breast cancer [52]. This evidence concerns the gene SOD2 and malignant endocrine neoplasm.